Publisher
Springer Science and Business Media LLC
Reference45 articles.
1. U.S. Department of Health and Human Services: Centers for Disease Control and Prevention. Antibiotic resistant threats in the United States, 2013. Available at
https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf
.
2. O’Neill J. Tackling drug-resistant infections globally: final report and recommendations: the review on antimicrobial resistance; 2016. Available from:https://
amr-review.org
.
3. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(1):1–12.
4. Pogue JM, Kaye KS, Cohen DA, Marchaim D. Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens. Clin Microbiol Infect. 2015;21:302–12.
https://doi.org/10.1016/j.cmi.2014.12.025
.
5. • Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2017;18:318–27.
https://doi.org/10.1016/S1473-3099(17)30753-3
Author used a decision analysis method to prioritize antibiotic-resistant bacteria to focus future development strategies.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献